Pages that link to "Q37176949"

The following pages link to Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy (Q37176949):

Displaying 14 items.

• Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population (Q34706677) (← links)
• Genotype and allele frequency of CYP2C19*17 in a healthy Iranian population (Q36469405) (← links)
• Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations. (Q38616806) (← links)
• Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region. (Q38651234) (← links)
• Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia (Q39033875) (← links)
• The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder (Q40569531) (← links)
• Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population (Q41432957) (← links)
• Effects of CYP2C19 variants on methadone metabolism in vitro (Q41991876) (← links)
• Selecting the optimum first-line treatment for H. pylori eradication (Q42682684) (← links)
• Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro (Q51008331) (← links)
• Prevalence of CYP2C19 Genetic Polymorphism among Normal People and Patients with Hepatic Diseases. (Q54257248) (← links)
• The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review (Q90072364) (← links)
• Genetic Polymorphism of CYP2C19 in Pakistani Population (Q90150739) (← links)
• Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe (Q92267103) (← links)